BMY vs PFE — Key Metrics
| Metric | BMY (Bristol-Myers Squibb Co) | PFE (Pfizer Inc) |
|---|---|---|
| Price | 54.01 | 25.220000000000002 |
| Market Cap | 109.76 Thousand | 143.74 Thousand |
| P/E (TTM) | 18.3648 | 19.1884 |
| P/B (Quarterly) | 6.1706 | 1.7532 |
| P/S (TTM) | 2.264 | 2.2703 |
| Net Profit Margin (TTM) | 12.33 | 11.83 |
| Gross Margin (TTM) | 53.71 | 74.8 |
| ROE (TTM) | 41.64 | 8.37 |
| Revenue Growth YoY (TTM) | 1.78 | 1.36 |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with real-time market insights and portfolio modeling.
Performance Comparison
Financial Metrics
| BMY | Metrics | PFE |
|---|---|---|
| $54.01 | Price | $25.22 |
| — | Market Capitalization | — |
| 9.14 | Price to Earning Ratio | 9.01 |
| 2.28 | Price to Revenue Ratio | 2.28 |
| 1.78% | Revenue Growth | 1.36% |
| 53.71% | Gross Profit Margin | 74.8% |
| 12.33% | Net Profit Margin | 11.83% |
|
Greatly Outperform |
AI Model Recommendation |
Outperform |
Recommendation SummaryStock BMY is projected to greatly outperform the market, stock PFE is projected to outperform the market. Upfront Recommendation: BMY. |
||
Stock Comparison
Proprietary AI Model
Proprietary AI Model
Cumulative Return Analysis
Top Holdings
| Symbol | Company | Weight |
|---|